For research use only. Not for therapeutic Use.
SSAA09E1(CAT: I036645) is a potent inhibitor of SARS-CoV replication, demonstrating its effectiveness by blocking viral entry through three distinct mechanisms. It interferes with viral fusion, receptor binding, and membrane interactions, making it a valuable tool for understanding coronavirus entry pathways. SSAA09E1 is particularly significant in virology and infectious disease research, where it aids in exploring therapeutic strategies to prevent viral infections. Its multifaceted mechanism of action offers a promising avenue for developing antiviral treatments against SARS-CoV and other coronaviruses, contributing to advancements in pandemic preparedness and drug discovery.
Catalog Number | I036645 |
CAS Number | 433212-75-0 |
Synonyms | SSAA09E1; SSAA09 E1; SSAA09-E1; |
Molecular Formula | C7H9N3S2 |
Purity | 98% |
Target | Metabolic Enzyme/Protease |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | [(Z)-1-Thiophen-2-ylethylideneamino]thiourea |
InChI | InChI=1S/C7H9N3S2/c1-5(9-10-7(8)11)6-3-2-4-12-6/h2-4H,1H3,(H3,8,10,11)/b9-5- |
InChIKey | PJVHAJJEMJNPHN-UITAMQMPSA-N |
SMILES | S=C(N)N/N=C(C1=CC=CS1)/C |